Free Trial

Promising Chinese Stocks To Research - April 25th

Charming Medical logo with Services background
Image from MarketBeat Media, LLC.

Key Points

  • MarketBeat's stock screener flagged five high-dollar-volume names to research: Charming Medical (MCTA), Diageo (DEO), UP Fintech (TIGR), RBB Bancorp (RBB), and Regencell Bioscience (RGC).
  • The picks span sectors — two Traditional Chinese Medicine firms (Charming Medical, Regencell), a China-focused online broker (UP Fintech), a regional bank serving Asian-American communities (RBB), and a global beverage company (Diageo) — offering varied exposure to China-related markets.
  • The article cautions that Chinese stocks carry unique risks, including local regulatory policy, currency risk, differing accounting standards, and potential market‑access constraints.
  • Interested in Charming Medical? Here are five stocks we like better.

Charming Medical, Diageo, UP Fintech, RBB Bancorp, and Regencell Bioscience are the five Chinese stocks to watch today, according to MarketBeat's stock screener tool. Chinese stocks are equity securities issued by companies that are incorporated in or primarily operate out of China—including mainland China and Hong Kong—and that are listed on Chinese exchanges (Shanghai and Shenzhen A-shares, Hong Kong H-shares) or on foreign exchanges as ADRs or ordinary listings. For investors the term denotes exposure to China’s economy and corporate sector and carries specific considerations such as local regulatory policy, currency risk, differing accounting standards, and potential market‑access constraints. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.

Charming Medical (MCTA)

We are a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products. We offer a wide range of beauty, wellness, and postpartum services and products rooted and influenced by the principles and practices of TCM, such as the use of herbal ingredients, acupuncture techniques, Tuina massage, and dietary guidance.

Read Our Latest Research Report on MCTA

Diageo (DEO)

Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.

Read Our Latest Research Report on DEO

UP Fintech (TIGR)

UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.

Read Our Latest Research Report on TIGR

RBB Bancorp (RBB)

RBB Bancorp operates as the bank holding company for Royal Business Bank that provides various banking products and services to the Chinese-American, Korean-American, and other Asian-American communities. Its deposit products include checking, savings, and money market accounts, as well as certificates of deposit.

Read Our Latest Research Report on RBB

Regencell Bioscience (RGC)

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.

Read Our Latest Research Report on RGC

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Charming Medical Right Now?

Before you consider Charming Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Charming Medical wasn't on the list.

While Charming Medical currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines